Literature DB >> 27927170

Erratum to: In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.

Anna Torres1, Joanna Kozak2, Agnieszka Korolczuk3, Paulina Wdowiak2, Ewa Domańska-Glonek2, Ryszard Maciejewski4, Kamil Torres4.   

Abstract

Entities:  

Year:  2016        PMID: 27927170      PMCID: PMC5141642          DOI: 10.1186/s12885-016-2971-0

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


× No keyword cloud information.

Erratum

After the publication of the article [1], the authors realised it contained an error with the Methods section. The following paragraph should be deleted from the original article:

Cell proliferation assay

Proliferation was measured using Delfia cell proliferation kit (Perkin-Elmer, Waltham, MA, USA) according to manufacturer protocol. BrdU incorporation was measured by time–resolved fluorescence 48 h after transfection using VictorX4 multimode plate reader (Perkin-Elmer, Waltham, MA, USA). All experiments were performed in triplicates and repeated tree times.
  1 in total

1.  In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.

Authors:  Anna Torres; Joanna Kozak; Agnieszka Korolczuk; Paulina Wdowiak; Ewa Domańska-Glonek; Ryszard Maciejewski; Kamil Torres
Journal:  BMC Cancer       Date:  2016-10-26       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.